UndisclosedStrategic acquisitionHealthcare & Life SciencesCompleted
Alaunos Therapeutics acquires Velaris Therapeutics
Velaris Therapeutics, a Paragon Labs-launched pulmonary hypertension biotech, has been acquired by Alaunos Therapeutics; terms were not disclosed.
Read the full coverage, free
We only link to sources you can read without a subscription. How we check.
Get healthcare deals like this every morning
The day's biggest deals in five minutes. Free, with no paywalled links.